Highbridge Capital Management’s Zimmer Biomet ZBH Stock Holding History

Highbridge Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,047	Closed	-$590K	–	1785
2017 Q4	$590K	Buy	+5,047	New	+$571K	0.01%	809
2014 Q1	–	Sell	-10,094	Closed	-$914K	–	1270
2013 Q4	$914K	Buy	10,094 +412	+4%	+$35.7K	0.01%	548
2013 Q3	$772K	Sell	9,682 -8,240	-46%	-$649K	0.01%	744
2013 Q2	$1.3M	Buy	+17,922	New	+$1.34M	0.01%	601

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Highbridge Capital Management's ZBH Position: Q4 2018 in Review

Highbridge Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 45,290 shares — an estimated $5.78M sold.

Highbridge Capital Management first reported a position in ZBH in Q2 2013 and held it in 19 quarters. The position peaked at $55.2M in Q3 2014. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

Highbridge Capital Management reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
Highbridge Capital Management sold 45,290 Zimmer Biomet shares in Q4 2018, an estimated $5.78M.
Highbridge Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 19 quarters.
Highbridge Capital Management's Zimmer Biomet position peaked at $55.2M in Q3 2014.
871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.